Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
- First Posted Date
- 2016-03-03
- Last Posted Date
- 2018-07-31
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT02698280
- Locations
- 🇨🇳
Huashan hospital, Fudan University, Shanghai, Shanghai, China
Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients
- Conditions
- HyperphosphatemiaEnd-stage Renal Disease
- First Posted Date
- 2016-02-18
- Last Posted Date
- 2018-02-26
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT02684643
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China
Effectiveness and Safety Study on Different Timing of Preventive Ileostomy Closure After Surgery for Rectal Cancer
- Conditions
- Rectal Cancer
- First Posted Date
- 2016-01-27
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT02665026
- Locations
- 🇨🇳
Huashan Hospital Affiliated to Fudan University, Shanghai, China
the Effects of Different Dietary Phosphorus Intake on the Circadian Pattern of Serum Phosphate in Normal Subjects
- Conditions
- Healthy
- First Posted Date
- 2015-12-21
- Last Posted Date
- 2016-08-17
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 6
- Registration Number
- NCT02636153
- Locations
- 🇨🇳
Huashan hospital, Shanghai Medical College, Fudan University, Shanghai, Shanghai, China
the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients
- Conditions
- Anemia, Iron-Deficiency
- Interventions
- Drug: ferrous succinate and vitamin C
- First Posted Date
- 2015-12-16
- Last Posted Date
- 2019-02-25
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 440
- Registration Number
- NCT02631668
- Locations
- 🇨🇳
Hushan Hospital, Shanghai, Shanghai, China
Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: PegIFN alfa-2a
- First Posted Date
- 2015-11-03
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT02594293
- Locations
- 🇨🇳
Wuhan Seventh People's Hospital, Wuhan, Hubei, China
🇨🇳Changzhou Third People's Hospital, Changzhou, Jiangsu, China
🇨🇳First Affiliated Hospital of Zhejiang University, Hangzhou, Jiangsu, China
Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 294
- Registration Number
- NCT02589652
- Locations
- 🇨🇳
The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China
🇨🇳The Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China
🇨🇳Beijing Ditan Hospital, Beijing, Beijing, China
Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects
- Conditions
- Pituitary Adenoma
- First Posted Date
- 2015-10-14
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT02574793
- Locations
- 🇨🇳
Xiaolong Zhao, Jing'an, Shanghai, China
Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem Treatment
- First Posted Date
- 2015-07-23
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 82
- Registration Number
- NCT02506686
Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2015-06-30
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 6
- Registration Number
- NCT02484755
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China